NVCT · ISSUER CIK 1875558
Nuvectis Pharma, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Nuvectis Pharma, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 5, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 202617:26 | Aug 3, 2026 | NVCT | Vice President, Finance | A · Grant | — | +30,000 | 230,118 | +15% | — |